ethylcholine aziridinium has been researched along with Inflammation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daniel, C; Geisslinger, G; Radeke, HH; Sartory, N; Stein, JM; Zahn, N | 1 |
| Chakravarti, S; Wu, F | 1 |
2 other study(ies) available for ethylcholine aziridinium and Inflammation
| Article | Year |
|---|---|
FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells.
Topics: Animals; Antigens, CD; Antigens, Differentiation; Aziridines; Cell Differentiation; Choline; Colitis; CTLA-4 Antigen; Cytokines; Disease Models, Animal; Down-Regulation; Fingolimod Hydrochloride; Forkhead Transcription Factors; Immunosuppressive Agents; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice; Mice, Inbred BALB C; Neuromuscular Blocking Agents; Propylene Glycols; Sphingosine; T-Lymphocytes, Regulatory; Th1 Cells | 2007 |
Differential expression of inflammatory and fibrogenic genes and their regulation by NF-kappaB inhibition in a mouse model of chronic colitis.
Topics: Animals; Aziridines; CD4-Positive T-Lymphocytes; Choline; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Disease Models, Animal; Extracellular Matrix; Female; Fibrosis; Gene Expression Profiling; Gene Expression Regulation; Inflammation; Macrophages; Mice; Neuromuscular Blocking Agents; Neutrophil Infiltration; Neutrophils; Oligodeoxyribonucleotides, Antisense; Oligonucleotide Array Sequence Analysis; Time Factors; Transcription Factor RelA | 2007 |